Cross-talk between angiotensin-II and toll-like receptor 4 triggers a synergetic inflammatory response in rat mesangial cells under high glucose conditions

Biochemical and Biophysical Research Communications

Volumn 459, Issue 2, 2015, Pages 264-269

  Lv, Jinlei ^a   Chen, Qinkai ^a   Shao, Yi ^a   Chen, Yuhua ^a   Shi, Jun ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Angiotensin II; High glucose; Inflammation; Mesangial cell; Toll like receptor 4

Indexed keywords

ANGIOTENSIN II; GLUCOSE; INTERLEUKIN 6; IRBESARTAN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CCL2 PROTEIN, RAT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYD88 PROTEIN, RAT; TLR4 PROTEIN, RAT;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL STIMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE SILENCING; HYPERGLYCEMIA; IMMUNOFLUORESCENCE; INFLAMMATION; INNATE IMMUNITY; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURFACE PROPERTY; TRANSIENT TRANSFECTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; DIABETIC NEPHROPATHIES; GENETICS; METABOLISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN II; ANIMALS; CELL LINE; CHEMOKINE CCL2; DIABETIC NEPHROPATHIES; GLUCOSE; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MESANGIAL CELLS; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; RATS; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 84925461337     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.02.096     Document Type: Article

References (36)

1. L. Chen, D.J. Maqliano, and P.Z. Zimmet The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives Nat. Rev. Endocrinol. 8 2011 228 236
2. S.M. Titan, J. M Vieira Jr., W.V. Dominguez, R.T. Barros, and R. Zatz ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a double-blind randomized clinical trial Clin. Nephrol. 76 2011 273 283
3. J.F. Navarro-Gonzalez, and C. Mora-Fernandez The role of inflammatory cytokines in diabetic nephropathy J. Am. Soc. Nephrol. 19 2008 433 442
4. A. Fornoni, A. Ijaz, T. Tejada, and O. Lenz Role of inflammation in diabetic nephropathy Curr. Diabetes Rev. 4 2008 10 17
5. M.D. Williams, and J.L. Nadler Inflammatory mechanisms of diabetic complications Curr. Diab. Rep. 7 2007 242 248
6. F.C. Brosius, C.C. Khoury, C.L. Buller, and S. Chen Abnormalities in signaling pathways in diabetic nephropathy Expert Rev. Endocrinol. Metab. 5 2010 51 64
7. F. Kim, M. Pham, I. Luttrell, D.D. Bannerman, J. Tupper, J. Thaler, T.R. Hawn, E.W. Raines, and M.W. Schwartz Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity Circ. Res. 100 2007 1589 1596
8. S. Devaraj, P. Tobias, and I. Jialal Knockout of toll-like receptor-4 attenuates the pro- inflammatory state of diabetes Cytokine 55 2011 441 445
9. R. Medzhitov, P. Preston-Hurlburt, and C.A. Janeway Jr. A human homologue of the drosophila toll protein signals activation of adaptive immunity Nature 388 1997 394 397
10. T. Kawai, and S. Akira The role of pattern-recognition receptors in innate immunity: update on toll-like receptors Nat. Immunol. 11 2010 373 384
11. H.J. Anders, B. Banas, and D. Schlöndorff Signaling danger: toll-like receptors and their potential roles in kidney disease J. Am. Soc. Nephrol. 15 2004 854 867
12. J. Chen, R. John, J.A. Richardson, J.M. Shelton, X.J. Zhou, Y. Wang, Q.Q. Wu, J.R. Hartono, P.D. Winterberg, and C.Y. Lu Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury Kidney Int. 79 2011 288 299
13. S. Devaraj, M.R. Dasu, S.H. Park, and I. Jialal Increased levels of ligands of toll-like receptors 2 and 4 in type 1 diabetes Diabetologia 52 2009 1665 1668
14. M.R. Dasu, S. Devaraj, S. Park, and I. Jialal Increased toll-like receptor activation and TLR ligands in recently diagnosed type2 diabetic subjects Diabetes Care 33 2010 861 868
15. M. Lin, W.H. Yiu, H.J. Wu, L.Y. Chan, J.C. Leung, W.S. Au, K.W. Chan, K.N. Lai, and S.C. Tang Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy J. Am. Soc. Nephrol. 23 2012 86 102
16. H. Kaur, A. Chien, and I. Jialal Hyperglycemia induced toll like receptor 4 expression and activity in mesangial cells: relevance to diabetic nephropathy Am. J. Physiol. Ren. Physiol. 30 2012 F1145 F1150
17. Y.M. Scindia, U.S. Deshmukh, and H. Bagavant Mesangial pathology in glomerular disease: targets for therapeutic intervention Adv. Drug Deliv. Rev. 62 2010 1337 1343
18. S.O. Kolset, F.P. Reinholt, and T. Jenssen Diabetic nephropathy and extracellular matrix J. Histochem. Cytochem. 60 2012 976 986
19. D.J. Leehey, A.K. Singh, N. Alavi, and R. Singh Role of angiotensin II in diabetic nephropathy Kidney Int. Suppl. 77 2000 S 93 98
20. R. Singh, N. Alavi, A.K. Singh, and D.J. Leehey Role of antgiotensin II in glucose-induced inhibition of mesangial matrix degradation Diabetes 48 1999 2066 2073
21. R. Singh, A.K. Singh, N. Alavi, and D.J. Leehey Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose J. Am. Soc. Nephrol. 14 2003 873 880
22. J. Lv, R. Jia, D. Yang, J. Zhu, and G. Ding Candesartan attenuates angiotensin II-induced mesangial cell apoptosis via TLR4/MyD88 pathway Biochem. Biophys. Res. Commun. 380 2009 81 86
23. M.R. Dasu, A.C. Riosvelasco, and I. Jialal Candesartan inhibits toll-like receptor expression and activity both in vitro and in vivo Atherosclerosis 202 2009 76 83
24. J. Lv, R. Jia, and G. Ding AngiotensinII induces inflammation factors' release via TLR4/MyD88 pathway in rat tubular epithelial cell Chin. J. Nephrol. 26 2010 780 785
25. R. Komers Renin inhibition in the treatment of diabetic kidney disease Clin. Sci. (Lond) 124 2013 553 566
26. T. Bondeva, J. Heinzig, S. Franke, and G. Wolf Angiotensin II differentially regulates Morg1 expression in kidney cells Am. J. Nephrol. 35 2012 442 455
27. G. Wolf, J. Bohlender, T. Bondeva, T. Roger, F. Thaiss, and U.O. Wenzel Angiotensin II upregulates toll-like receptor 4 on mesangial cells J. Am. Soc. Nephrol. 17 2006 1585 1593
28. M. Ruiz-Ortega, M. Ruperez, O. Lorenzo, V. Esteban, J. Blanco, S. Mezzano, and J. Egido Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney Kidney Int. Suppl. 82 2002 S12 S22
29. M.R. Dasu, S. Devaraj, L. Zhao, D.H. Hwang, and I. Jialal High glucose induces toll-like receptor expression in human monocytes: mechanism of activation Diabetes 57 2008 3090 3098
30. Y. Suzuki, M. Ruiz-Ortega, O. Lorenzo, M. Ruperez, V. Esteban, and J. Egido Inflammation and angiotensin II Int. J. Biochem. Cell. Biol. 35 2003 881 900
31. J.C. Pickup, M.B. Mattock, G.D. Chusney, and D. Burt NIDDM as a disease of the innate immune system:association of acutephase reactants and interleukin-6 with metabolic syndrome X Diabetologia 40 1997 1286 1292
32. H.O. El Mesallamy, Ahmed HH, Bassyouni AA, and A.S. Ahmed Clinical significance of inflammatory and fibrogenic cytokines in diabetic nephropathy Clin. Biochem. 45 2012 646 650
33. Y. Shirai, H. Yoshiji, R. Noguchi, K. Kaji, Y. Aihara, A. Douhara, K. Moriya, T. Namisaki, H. Kawaratani, and H. Fukui Cross talk between toll-like receptor-4 signaling and Angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis J. Gastroenterol. Hepatol. 28 2013 723 730
34. Y. Ji, J. Liu, Z. Wang, and N. Liu Angiotensin II induces inflammatory response partly via toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells Cell. Physiol. Biochem. 23 2009 265 276
35. M.R. Dasu, S. Ramirez, and R.R. Isseroff Toll-like receptors and diabetes: a therapeutic perspective Clin. Sci. (Lond) 122 2012 203 214
36. C.A. Veloso, J.S. Fernandes, C.M. Volpe, F.S. Fagundes-Netto, J.S. Reis, M.M. Chaves, and J.A. Nogueira-Machado TLR4 and RAGE: similar routes leading to inflammation in type 2 diabetic patients Diabetes Metab. 37 2011 336 342